Browsing Tag
invasive candidiasis
3 posts
SCY-247 intravenous trial signals strategic shift in SCYNEXIS, Inc.’s antifungal pipeline
SCYNEXIS, Inc. advances IV SCY-247 into Phase 1. Discover what this signals for antifungal resistance and hospital markets.
Mundipharma’s rezafungin cleared by MHRA for invasive candidiasis in Great Britain
In a significant advancement for antifungal therapy, Napp Pharmaceuticals Limited, a key player within the international network of…
Cidara Therapeutics’ REZZAYO bags UK and EU approvals in invasive candidiasis
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing life-saving therapies, announced a significant breakthrough with…